<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tucker EI</submitter><funding>NHLBI NIH HHS</funding><funding>NIH HHS</funding><pagination>689-699</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7046603</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>135(9)</volume><pubmed_abstract>Although thrombin is a key enzyme in the coagulation cascade and is required for both normal hemostasis and pathologic thrombogenesis, it also participates in its own negative feedback via activation of protein C, which downregulates thrombin generation by enzymatically inactivating factors Va and VIIIa. Our group and others have previously shown that thrombin's procoagulant and anticoagulant activities can be effectively disassociated to varying extents through site-directed mutagenesis. The thrombin mutant W215A/E217A (WE thrombin) has been one of the best characterized constructs with selective activity toward protein C. Although animal studies have demonstrated that WE thrombin acts as an anticoagulant through activated protein C (APC) generation, the observed limited systemic anticoag</pubmed_abstract><journal>Blood</journal><pubmed_title>The protein C activator AB002 rapidly interrupts thrombus development in baboons.</pubmed_title><pmcid>PMC7046603</pmcid><funding_grant_id>R01 HL049413</funding_grant_id><funding_grant_id>R01 HL147821</funding_grant_id><funding_grant_id>R01 HL139554</funding_grant_id><funding_grant_id>R29 HL049413</funding_grant_id><funding_grant_id>R44 HL095315</funding_grant_id><funding_grant_id>P51 OD011092</funding_grant_id><funding_grant_id>R44 HL117589</funding_grant_id><pubmed_authors>Lorentz CU</pubmed_authors><pubmed_authors>Wood DC</pubmed_authors><pubmed_authors>McCarty OJT</pubmed_authors><pubmed_authors>Pelc LA</pubmed_authors><pubmed_authors>Gruber A</pubmed_authors><pubmed_authors>Markway BD</pubmed_authors><pubmed_authors>Wallisch M</pubmed_authors><pubmed_authors>Hinds MT</pubmed_authors><pubmed_authors>Shatzel JJ</pubmed_authors><pubmed_authors>Di Cera E</pubmed_authors><pubmed_authors>Tucker EI</pubmed_authors><pubmed_authors>Verbout NG</pubmed_authors></additional><is_claimable>false</is_claimable><name>The protein C activator AB002 rapidly interrupts thrombus development in baboons.</name><description>Although thrombin is a key enzyme in the coagulation cascade and is required for both normal hemostasis and pathologic thrombogenesis, it also participates in its own negative feedback via activation of protein C, which downregulates thrombin generation by enzymatically inactivating factors Va and VIIIa. Our group and others have previously shown that thrombin's procoagulant and anticoagulant activities can be effectively disassociated to varying extents through site-directed mutagenesis. The thrombin mutant W215A/E217A (WE thrombin) has been one of the best characterized constructs with selective activity toward protein C. Although animal studies have demonstrated that WE thrombin acts as an anticoagulant through activated protein C (APC) generation, the observed limited systemic anticoag</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Feb</publication><modification>2026-04-29T12:58:05.634Z</modification><creation>2026-04-07T15:15:20.206Z</creation></dates><accession>S-EPMC7046603</accession><cross_references><pubmed>31977000</pubmed><doi>10.1182/blood.2019002771</doi></cross_references></HashMap>